Fermenta Biotech Q1FY27: India Mix Improves as Animal Nutrition Drags Margins

Consolidated total income was 126.2 crore, EBITDA was 22.4 crore and profit after tax was 9.5 crore in Q1FY27.

Excluding real estate value unlocking, India accounted for 47 percent of revenue, Europe 23 percent, North America 10 percent and Others 20 percent in Q1FY27.

Vitamin D3 human nutrition was 76.5 crore, Vitamin D3 animal nutrition was 12.6 crore, Other APIs and intermediates were 11.6 crore and Nutrition Others were 11.0 crore in Q1FY27.

The company stated that Q1FY26 included 2.7 crore of non-recurring insurance income and 1.6 crore of real estate value unlocking, which did not recur in Q1FY27.

The company stated that VITADEE Green received FSSAI approval on 6 July 2026 for use in health supplements, nutraceuticals and food products.

Animal nutrition was weak with volumes down 52 percent QoQ and 20 percent YoY and average realisation down 40 percent YoY; the company indicated it chose volume discipline over chasing weak prices.